# OnCo record invictus-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/invictus-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "invictus-therapeutics" ;
  schema:name "Invictus Therapeutics"@en ;
  schema:alternateName "Invictus Therapeutics Ltd"@en, "VGI Health Technology Limited"@en, "VGI Health Technology"@en, "Invictus Ops Pty Ltd"@en ;
  schema:description "An Australian company developing medicines and supplements from tocotrienols, a form of vitamin E. Its cancer programme is a tocotrienol dissolved under the tongue, to be tested alongside standard treatment in advanced pancreatic cancer."@en ;
  schema:url <https://onco.cc/companies/invictus-therapeutics/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.nsx.com.au/ftp/news/021745076.PDF>, <https://abnnewswire.net/press/en/122891/VGI-Health-Technology-Limited-(NSX-VTL)-HREC-Approval-for-Phase-II-Clinical-Study.html>, <https://abr.business.gov.au/ABN/View?abn=35111082485> ;
  schema:addressCountry "AU" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:drugs <https://onco.cc/drugs/ivb003/> .